{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:31:21Z","timestamp":1787059881565,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008644","name":"McGill University Faculty of Medicine and Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neuint.2026.106226","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:38:54Z","timestamp":1784536734000},"page":"106226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early treatment with naproxen alters hippocampal metabolites in the TgF344-AD rat model of Alzheimer's disease"],"prefix":"10.1016","volume":"199","author":[{"given":"Caitlin F.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9994-4207","authenticated-orcid":false,"given":"Elena","family":"Osipyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Devenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Madularu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Breitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3516-936X","authenticated-orcid":false,"given":"Jamie","family":"Near","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11 Suppl. l","key":"10.1016\/j.neuint.2026.106226_bib1","article-title":"COX-1 and COX-2 in health and disease","volume":"99","author":"Adelizzi","year":"1999","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.neuint.2026.106226_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2022.12.015","article-title":"The TgF344-AD rat: behavioral and proteomic changes associated with aging and protein expression in a transgenic rat model of Alzheimer's disease","volume":"123","author":"Bac","year":"2023","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neuint.2026.106226_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/nbm.1122","article-title":"Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T","volume":"20","author":"Bartha","year":"2007","journal-title":"NMR Biomed."},{"issue":"9","key":"10.1016\/j.neuint.2026.106226_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib5","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J.Stat.Softw Artic"},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc., Ser. B Stat. Methodol."},{"key":"10.1016\/j.neuint.2026.106226_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuroimage.2012.10.065","article-title":"Alzheimer's Disease Neuroimaging Initiative. Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models","volume":"66","author":"Bernal-Rusiel","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuint.2026.106226_bib8","series-title":"Chapter 2.5 - Other Significant Metabolites: Myo-Inositol, GABA, Glutamine, and Lactate","first-page":"122","author":"Best","year":"2014"},{"key":"10.1016\/j.neuint.2026.106226_bib9","first-page":"289","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1993","journal-title":"Dev. Neurosci."},{"issue":"22","key":"10.1016\/j.neuint.2026.106226_bib10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","article-title":"Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort","volume":"72","author":"Breitner","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2026.106226_bib11","series-title":"4 - REGULATION OF ENERGY METABOLISM","first-page":"157","volume":"Second","author":"Brody","year":"1999"},{"issue":"11","key":"10.1016\/j.neuint.2026.106226_bib12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","article-title":"Brain metabolism in health, aging, and neurodegeneration","volume":"36","author":"Camandola","year":"2017","journal-title":"EMBO J."},{"issue":"14","key":"10.1016\/j.neuint.2026.106226_bib13","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.7150\/thno.56059","article-title":"Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study","volume":"11","author":"Chaney","year":"2021","journal-title":"Theranostics"},{"issue":"15","key":"10.1016\/j.neuint.2026.106226_bib14","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.neuropsych.20060152","article-title":"Drug development for psychotropic, Cognitive-Enhancing, and disease-modifying treatments for Alzheimer's disease","volume":"33","author":"Cummings","year":"2021","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuint.2026.106226_bib16","series-title":"In Vivo NMR Spectroscopy","article-title":"Basic principles","author":"de Graaf","year":"2018"},{"issue":"37","key":"10.1016\/j.neuint.2026.106226_bib17","article-title":"Modeling Alzheimer's disease in transgenic rats","volume":"8","author":"Do Carmo","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JAD-190408","article-title":"Global metabolic shifts in Age and Alzheimer's disease mouse brains pivot at NAD+\/NADH Redox sites","volume":"71","author":"Dong","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuint.2026.106226_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI18162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jmrb.1993.1055","article-title":"Absolute quantitation of water and metabolites in the human brain. Compart","volume":"102","author":"Ernst","year":"1993","journal-title":"Water J. Magn .Reson B."},{"key":"10.1016\/j.neuint.2026.106226_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2020.12.012","article-title":"Longitudinal quantification of metabolites and macromolecules reveals age- and sex-related changes in the healthy Fischer 344 rat brain","volume":"101","author":"Fowler","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2026.106226_bib22","series-title":"An R Companion to Applied Regression","author":"Fox","year":"2019"},{"key":"10.1016\/j.neuint.2026.106226_bib23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/mrm.1910290613","article-title":"Automatic, localized in vivo adjustment of all First- and second-order shim coils","volume":"29","author":"Gruetter","year":"1993","journal-title":"J. Magn. Reson Med."},{"key":"10.1016\/j.neuint.2026.106226_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/gastro\/goac017","article-title":"Convergent pathways of the gut microbiota\u2013brain axis and neurodegenerative disorders","volume":"10","author":"Gubert","year":"2022","journal-title":"Gastroenterol. Rep."},{"issue":"456","key":"10.1016\/j.neuint.2026.106226_bib25","article-title":"A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease","volume":"11","author":"Hampel","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neuint.2026.106226_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106226_bib27","volume":"vol. 16","author":"Iglewicz","year":"1997"},{"key":"10.1016\/j.neuint.2026.106226_bib28","first-page":"19","article-title":"Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2026.106226_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"19","key":"10.1016\/j.neuint.2026.106226_bib30","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/WNL.0000000000002680","article-title":"MR spectroscopy, APOE genotype, and evolving \u03b2-amyloid pathology: what is being detected and when","volume":"86","author":"Kantarci","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer's disease: key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"13","key":"10.1016\/j.neuint.2026.106226_bib33","article-title":"lmerTest package: tests in Linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J .Stat. Softw. [Internet]"},{"key":"10.1016\/j.neuint.2026.106226_bib34","article-title":"Magnetic resonance spectroscopy in the rodent brain: experts' consensus recommendations","volume":"26","author":"Lanz","year":"2020","journal-title":"NMR Biomed. Publ. Online"},{"issue":"4","key":"10.1016\/j.neuint.2026.106226_bib35","first-page":"229","article-title":"Alzheimer's progression score\u2019: development of a Biomarker Summary outcome for AD prevention trials","volume":"3","author":"Leoutsakos","year":"2016","journal-title":"J. Prev. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neuint.2026.106226_bib36","article-title":"Wanted dead or alive? The tradeoff between in-vivo versus ex-vivo MR brain imaging in the mouse","volume":"6","author":"Lerch","year":"2012","journal-title":"Front. Neuroinf."},{"issue":"4","key":"10.1016\/j.neuint.2026.106226_bib37","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jesp.2013.03.013","article-title":"Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median","volume":"49","author":"Leys","year":"2013","journal-title":"J. Exp. Soc. Psychol."},{"issue":"6","key":"10.1016\/j.neuint.2026.106226_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/13550280290100969","article-title":"Local neuroinflammation and the progression of Alzheimer's disease","volume":"8","author":"McGeer","year":"2002","journal-title":"J. Neurovirol."},{"issue":"5","key":"10.1016\/j.neuint.2026.106226_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"18","key":"10.1016\/j.neuint.2026.106226_bib40","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007232","article-title":"INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease","volume":"92","author":"Meyer","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neuint.2026.106226_bib41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jnc.13411","article-title":"The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease","volume":"136","author":"Minter","year":"2016","journal-title":"J. Neurochem."},{"issue":"Pt 1","key":"10.1016\/j.neuint.2026.106226_bib42","article-title":"Pharmaceuticals as emerging pollutants: case naproxen an overview","volume":"291","author":"Moreno R\u00edos","year":"2022","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.neuint.2026.106226_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/nbm.1062","article-title":"Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS","volume":"19","author":"Mueller","year":"2006","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20962-6","article-title":"Spatio-temporal metabolic rewiring in the brain of TgF344-AD rat model of Alzheimer's disease","volume":"12","author":"Mu\u00f1oz-Moreno","year":"2022","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.neuint.2026.106226_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1148\/radiol.13130531","article-title":"Clinical proton MR spectroscopy in central nervous system disorders","volume":"270","author":"Oz","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.neuint.2026.106226_bib46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2017.09.024","article-title":"Anxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease","volume":"61","author":"Pentkowski","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neuint.2026.106226_bib47","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1194\/jlr.M500397-JLR200","article-title":"Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells","volume":"47","author":"P\u00e9rez","year":"2006","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.neuint.2026.106226_bib48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","article-title":"Automatic quantitation of localized in vivo 1H spectra with LCModel","volume":"14","author":"Provencher","year":"2001","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuint.2026.106226_bib49","series-title":"R: a Language and Environment for Statistical Computing","year":"2020"},{"issue":"6","key":"10.1016\/j.neuint.2026.106226_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061292","article-title":"Taurine supplementation as a neuroprotective strategy upon brain dysfunction in Metabolic syndrome and diabetes","volume":"14","author":"Rafiee","year":"2022","journal-title":"Nutrients"},{"issue":"21","key":"10.1016\/j.neuint.2026.106226_bib51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/01.wnl.0000260269.93245.d2","article-title":"Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial","volume":"68","author":"Research Group","year":"2007","journal-title":"Neurology"},{"issue":"2\u20133","key":"10.1016\/j.neuint.2026.106226_bib52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresrev.2003.11.001","article-title":"Magnetic resonance spectroscopy in cognitive research","volume":"44","author":"Ross","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiology.195.1.7892497","article-title":"Probable Alzheimer disease: diagnosis with proton MR spectroscopy","volume":"195","author":"Shonk","year":"1995","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/mrm.26091","article-title":"Advanced processing and simulation of MRS data using the FID appliance (FID-A)-An open source, MATLAB-based toolkit","volume":"77","author":"Simpson","year":"2017","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neuint.2026.106226_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.nbd.2017.11.014","article-title":"Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer\u2019s Disease Rat Model","volume":"110","author":"Smith","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"16","key":"10.1016\/j.neuint.2026.106226_bib56","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl. Acad. Sci.U A"},{"key":"10.1016\/j.neuint.2026.106226_bib57","author":"Thomas"},{"key":"10.1016\/j.neuint.2026.106226_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","article-title":"In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time","volume":"41","author":"Tk\u00e1c","year":"1999","journal-title":"Magn. Reson. Med."},{"issue":"9 Pt B","key":"10.1016\/j.neuint.2026.106226_bib59","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta BBA - Biomembr."},{"issue":"1","key":"10.1016\/j.neuint.2026.106226_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.neuint.2026.106226_bib61","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1172\/JCI39716","article-title":"NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease","volume":"119","author":"Varvel","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"19","key":"10.1016\/j.neuint.2026.106226_bib62","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuint.2026.106226_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/JAD-141506","article-title":"Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis","volume":"44","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"43","key":"10.1016\/j.neuint.2026.106226_bib64","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J. Open Source Softw."},{"issue":"Pt 7","key":"10.1016\/j.neuint.2026.106226_bib65","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/brain\/aww117","article-title":"Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice","volume":"139","author":"Woodling","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2026.106226_bib66","series-title":"WorldAlzheimer'sReport 2022","year":"2022"},{"key":"10.1016\/j.neuint.2026.106226_bib67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2016.04.200","article-title":"Energy metabolism and inflammation in brain aging and Alzheimer's disease","volume":"100","author":"Yin","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"83","key":"10.1016\/j.neuint.2026.106226_bib68","article-title":"NSAID exposure and risk of Alzheimer's disease: an updated meta-analysis from cohort studies","volume":"10","author":"Zhang","year":"2018","journal-title":"Front. Aging Neurosci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:18:43Z","timestamp":1787059123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018626001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":67,"alternative-id":["S0197018626001178"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106226","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early treatment with naproxen alters hippocampal metabolites in the TgF344-AD rat model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106226"}}